Edward Ludwig - CVS Health Independent Director
| CVS Stock | USD 64.48 0.62 0.97% |
Director
Mr. Edward J. Ludwig is Independent Director of the Company. He is the lead director of Aetnas board of directors and was a director at Aetna since 2003. He is the former Chairman of the board of directors of Becton, Dickinson and Company, having served in this position from February 2002 through June 2012. He also served as Chief Executive Officer of BD from January 2000 to September 2011, President of BD from May 1999 to December 2008, and Chief Financial Officer of BD from January 1995 to May 1999. Mr. Ludwig joined BD as a Senior Financial Analyst in 1979. Prior to joining BD, Mr. Ludwig was a senior auditor with Coopers and Lybrand where he earned his CPA, and served as a financial and strategic analyst at Kidde, Inc. Mr. Ludwig also served as Director of Xylem, Inc. from 2011 to 2017, and Chairman of Advanced Medical Technology Association, or AdvaMed, from 2006 to 2008. He serves as the lead independent director on the board of directors of Boston Scientific Corporation and as a director of POCARED Diagnostics Ltd. . since 2018.
| Age | 69 |
| Tenure | 7 years |
| Address | One CVS Drive, Woonsocket, RI, United States, 02895 |
| Phone | 401 765 1500 |
| Web | https://www.cvshealth.com |
CVS Health Management Efficiency
The company has Return on Asset of 0.0199 % which means that on every $100 spent on assets, it made $0.0199 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0602 %, implying that it generated $0.0602 on every 100 dollars invested. CVS Health's management efficiency ratios could be used to measure how well CVS Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to gain to 0.12 in 2025, whereas Return On Tangible Assets are likely to drop 0.03 in 2025. At this time, CVS Health's Asset Turnover is comparatively stable compared to the past year.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Dale Wolf | Molina Healthcare | 66 | |
| James OBrien | Humana Inc | 66 | |
| Gail Wilensky | UnitedHealth Group Incorporated | 76 | |
| Eric Wiseman | Cigna Corp | 65 | |
| Orlando Ayala | Centene Corp | 64 | |
| David Steward | Centene Corp | 68 | |
| Frank Bisignano | Humana Inc | 62 | |
| David Jones | Humana Inc | 71 | |
| John Noseworthy | UnitedHealth Group Incorporated | 69 | |
| Timothy Flynn | UnitedHealth Group Incorporated | 64 | |
| Michele Hooper | UnitedHealth Group Incorporated | 68 | |
| William McDonald | Humana Inc | 64 | |
| Richard Zoretic | Molina Healthcare | 62 | |
| Kimberly Ross | Cigna Corp | 56 | |
| William Ballard | UnitedHealth Group Incorporated | 77 | |
| Richard Schapiro | Molina Healthcare | 65 | |
| Karen Katz | Humana Inc | 64 | |
| Garrey Carruthers | Molina Healthcare | 80 | |
| John Partridge | Cigna Corp | 71 | |
| Frederick Eppinger | Centene Corp | 62 | |
| Valerie Rice | UnitedHealth Group Incorporated | 58 | |
Management Performance
| Return On Equity | 0.0602 | ||||
| Return On Asset | 0.0199 |
CVS Health Corp Leadership Team
Elected by the shareholders, the CVS Health's board of directors comprises two types of representatives: CVS Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CVS. The board's role is to monitor CVS Health's management team and ensure that shareholders' interests are well served. CVS Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CVS Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Edward Ludwig, Independent Director | ||
| Sreekanth MD, Executive Officer | ||
| David Dorman, Independent Chairman of the Board | ||
| Shawn Guertin, Chief Financial Officer, Executive Vice President | ||
| Mary Schapiro, Independent Director | ||
| FACEP MD, VP Officer | ||
| Fernando Aguirre, Independent Director | ||
| Laurence McGrath, Senior Relations | ||
| Laurie Havanec, Chief People Officer, Executive Vice President | ||
| Norman Greve, Chief Officer | ||
| C Brown, Independent Director | ||
| NancyAnn DeParle, Independent Director | ||
| David CEBS, Executive Caremark | ||
| Tilak Mandadi, Data, Digital | ||
| Thomas Cowhey, Executive CFO | ||
| JeanPierre Millon, Independent Director | ||
| Alecia DeCoudreaux, Independent Director | ||
| William Weldon, Independent Director | ||
| Larry McGrath, Sr Relations | ||
| Samrat Esq, Chief VP | ||
| Joshua Flum, Executive Vice President, Chief Strategy and Business Development Officer | ||
| Heidi Capozzi, Executive Officer | ||
| Troyen Brennan, Executive Vice President Chief Medical Officer | ||
| Prem Shah, Executive Vice President, Chief Pharmacy Officer and Co-President of Retail | ||
| Lisa Bisaccia, Chief Human Resource Officer, Executive Vice President | ||
| Karen Lynch, President, Chief Executive Officer, Director | ||
| Thomas Moriarty, Executive Vice President, General Counsel, Chief Policy and External Affairs Officer | ||
| Katerina Guerraz, Chief VP | ||
| Tony White, Independent Director | ||
| Anne Finucane, Independent Director | ||
| Vijay Patel, Senior CoFounder | ||
| James Clark, Senior Vice President - Controller, Chief Accounting Officer | ||
| Eva Boratto, Chief Financial Officer, Executive Vice President | ||
| David Falkowski, Executive Officer | ||
| Prem PharmD, Executive President | ||
| Jonathan Roberts, Chief Operating Officer, Executive Vice President | ||
| Gustavo Giraldo, Head Benefits | ||
| Daniel Finke, Executive Vice President and Presidentident - Health Care Benefits Segment | ||
| Larry Merlo, President, Chief Executive Officer, Director | ||
| Alan Lotvin, Executive Vice President and Presidentident - CVS Caremark | ||
| Neela Montgomery, Executive Vice President and President - CVS Pharmacy/Retail | ||
| Alan MD, Ex Services | ||
| Roger Farah, Independent Director | ||
| Sheryl Burke, Chief Responsibility | ||
| MPP MD, Senior President | ||
| Michelle Peluso, Executive Vice President, Chief Customer Officer and Co-President of Retail |
CVS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CVS Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0602 | ||||
| Return On Asset | 0.0199 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 152.44 B | ||||
| Shares Outstanding | 1.26 B | ||||
| Shares Owned By Insiders | 0.35 % | ||||
| Shares Owned By Institutions | 84.97 % | ||||
| Number Of Shares Shorted | 21.35 M | ||||
| Price To Earning | 42.99 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for CVS Stock Analysis
When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.